Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia. - Wikidata - awgldk - TriplyDB

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

http://www.wikidata.org/entity/Q37421821

about

Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissue Critical signal transduction pathways in CLL.Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.

P2860

Q33817641-ADCDBF18-4F6B-4675-9FE1-460C48DDD49F Q33897971-121B50EF-CF21-4515-B15F-D5176A4A6370 Q37571068-D1564621-355D-4523-A767-1FB36FAB2A6A Q37591356-B6598347-27BE-4F4F-897C-62988B522B97 Q37694617-875C89D7-5B9C-4180-B17D-9748E7E4E84E

P2860

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

http://www.wikidata.org/entity/Q37421821

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pretreatment angiogenic cytoki ...... chronic lymphocytic leukaemia.

@en

Pretreatment angiogenic cytoki ...... chronic lymphocytic leukaemia.

@nl

type

label

Pretreatment angiogenic cytoki ...... chronic lymphocytic leukaemia.

@en

Pretreatment angiogenic cytoki ...... chronic lymphocytic leukaemia.

@nl

prefLabel

Pretreatment angiogenic cytoki ...... chronic lymphocytic leukaemia.

@en

Pretreatment angiogenic cytoki ...... chronic lymphocytic leukaemia.

@nl

P1433

Q37421821-4E5A2BDB-B44A-43E7-B630-25833B9458FE

P1476

Q37421821-173719F6-FE33-404B-8CE0-5861864D424C

P2093

Q37421821-08B3966C-7EE2-4C25-AA64-FCBB9128C0C2

Q37421821-374496F7-2385-4249-914B-098AF5FF1784

Q37421821-494F13D8-738C-4050-B1DF-F7F1667DD12B

Q37421821-68AE214F-43C9-47AD-9F72-80A4DCA3AD74

Q37421821-8AF57728-70D8-48D5-80A4-DE3D721D8296

Q37421821-98F7BA73-2755-436B-A445-39DC1F90EAAC

Q37421821-A0629E60-91D8-4B9F-BBAD-7817DA85538C

Q37421821-BC30AFF7-A8F8-451D-9E3D-74C7828899E8

P2860

Q37421821-2E94E36F-71CF-46CD-B1A8-B533F308A744

Q37421821-35776DCE-AD9A-4424-A9AF-86D4A4BF1A95

Q37421821-39FB58BE-D30B-4E39-880A-C56B09BFD996

Q37421821-478C819D-6694-41C3-A0E9-B55271DE83A0

Q37421821-6B080D58-73B3-43EA-9B24-993C9F2A27FF

Q37421821-9BF8B4F3-C470-447E-A2F3-3E5C9599355C

Q37421821-AB058F54-FEFC-4767-8E69-BAA9D0902C4F

Q37421821-B1EC8659-B3AA-4BA8-B17F-D2DFDCEC4B9B

Q37421821-D4B7069F-20A9-4ECD-A87B-E119684BE372

Q37421821-EF5C9748-9376-4134-8BED-AC1A258466EB

P304

Q37421821-A16D6955-31AA-4C84-850B-4BD325ED4B0F

P31

Q37421821-439143E8-22A2-400A-9A3B-369E55D62CF4

P356

Q37421821-4C26AA51-2D71-4FB4-9B30-52BCAD096854

P407

Q37421821-E4E8707A-3F90-48EC-A0AC-3986C56B536B

P433

Q37421821-30FD3A19-6FC5-4D83-B53A-D96FF2741F1F

P478

Q37421821-3A099B4E-57B9-42B7-88E1-C23BF7A17BD9

P50

Q37421821-FF6759F7-275B-4147-BB12-BE7D0AC9C022

P577

Q37421821-0AC29B19-AD00-4F4C-9876-CA09DEC1F594

P5875

Q37421821-8914B82C-0892-4C22-8143-A9696743216F

P698

Q37421821-AAE3CE67-B8C7-4934-9021-5263DE28A35E

P921

Q37421821-2AE9EF22-8470-4EC5-995A-9A76F3A7EBC9

Q37421821-D98AFE77-2587-49F8-82E1-91B9B737D87C

P932

Q37421821-85CEF509-A3AE-4795-AC03-614C62BD66E3

P356

J.1365-2141.2009.07811.X

P1433

British Journal of Haematology

P1476

Pretreatment angiogenic cytoki ...... chronic lymphocytic leukaemia.

@en

P2093

Betsy LaPLant

http://www.w3.org/2001/XMLSchema#string

Charla Secreto

http://www.w3.org/2001/XMLSchema#string

Clive S Zent

http://www.w3.org/2001/XMLSchema#string

Michael R Grever

http://www.w3.org/2001/XMLSchema#string

Neil E Kay

http://www.w3.org/2001/XMLSchema#string

Tait D Shanafelt

http://www.w3.org/2001/XMLSchema#string

Thomas S Lin

http://www.w3.org/2001/XMLSchema#string

Tim Call

http://www.w3.org/2001/XMLSchema#string

P2860

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.

The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.

The history of the angiogenic switch concept.

Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.

P304

660-664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2009.07811.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26672683

http://www.w3.org/2001/XMLSchema#string

P698

19604237

http://www.w3.org/2001/XMLSchema#string

P921

P932

2777697

http://www.w3.org/2001/XMLSchema#string